Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients

Thrombosis Research

Volumn 135, Issue 2, 2015, Pages 298-302

  Delluc, Aurélien ^a   Le Gal, Grégoire ^a,b   Scarvelis, Dimitrios ^b   Carrier, Marc ^b,c  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c INSTITUT DU SAVOIR MONTFORT   (Canada)

Author keywords

Cancer; Central venous catheters; Upper extremity deep vein thrombosis

Indexed keywords

ANTIVITAMIN K; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; TINZAPARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CANCER PATIENT; CANCER REGRESSION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; IMPLANTABLE PORT SYSTEM; INJECTION SITE REACTION; LEG; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; METASTASIS; OUTCOME ASSESSMENT; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SKIN MANIFESTATION; SUPERIOR CAVA VEIN; TREATMENT DURATION; UPPER EXTREMITY DEEP VEIN THROMBOSIS; ADVERSE EFFECTS; COMPLICATION; MIDDLE AGED; NEOPLASM; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

CENTRAL VENOUS CATHETERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 84921599079     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.11.020     Document Type: Article

References (11)

1. Grant JD, Stevens SM, Woller SC, Lee EW, Kee ST, Liu DM, et al. Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost 2012;108:1097-108.
2. Verso M, Agnelli G. Venous thromboembolism associated with long-termuse of central venous catheters in cancer patients. J Clin Oncol 2003;21:3665-75.
3. Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost 2013;11:71-80.
4. Zwicker J, Connolly G, Carrier M, Kamphuisen P, Lee A. Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2014;12:796-800.
5. Akl EA, Labedi N, Barba M, Terrenato I, Sperati F, Muti P, et al. Anticoagulation for the long-term treatment of venous thromboembolismin patients with cancer. Cochrane Database Syst Rev 2011:CD006650.
6. Kovacs MJ, Kahn SR, Rodger M, Anderson DR, Andreou R, Mangel JE, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007;5:1650-3.
7. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e419S-94S.
8. Carrier M, Khorana AA, Zwicker JI, Lyman GH, Le Gal G, Lee AYY. Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis. J Thromb Haemost 2012;10:2599-601.
9. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3:692-4.
10. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111:4902-7.
11. Carrier M, Khorana AA, Moretto P, Le Gal G, Karp R, Zwicker JI. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer. Am J Med 2014;127:82-6.